Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural GlioblastomaRebecca S. Lescarbeau, Forest M. White, Peter Canoll et al.|Molecular Cancer Therapeutics|2016Cited by 38
Characterization of <i>In Vivo</i> Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of ResistanceKristina B. Emdal, Forest M. White, Sheri L. Moores et al.|Molecular Cancer Therapeutics|2017Cited by 31
Phosphotyrosine Profiling of NSCLC Cells in Response to EGF and HGF Reveals Network Specific Mediators of InvasionHannah Johnson, Forest M. White, Rebecca S. Lescarbeau et al.|Journal of Proteome Research|2013Cited by 30
Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural GlioblastomaRebecca S. Lescarbeau, Forest M. White, Katrina K. Bakken et al.|Molecular Cancer Therapeutics|2016Cited by 5
Characterization of in vivo resistance to osimertinib and JNJ-61186372, an EGFR/Met bi-specific antibody, reveals unique and consensus mechanisms of resistanceKristina B. Emdal, Forest M. White, Sheri L. Moores et al.|PMC|2017Cited by 3